Medomics New Novel Virus & Influenza a/B Rapid Test Kit

Product Details
Customization: Available
Classification: Test Kit
Type: Test Kit
Still deciding? Get samples of US$ 2.5/Piece
Request Sample
Gold Member Since 2020

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Experienced Team
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
Exhibition Experience
The supplier had participated in offline trade shows, you can check the Audit Report for more information
to see all verified strength labels (26)
  • Medomics New Novel Virus & Influenza a/B Rapid Test Kit
  • Medomics New Novel Virus & Influenza a/B Rapid Test Kit
  • Medomics New Novel Virus & Influenza a/B Rapid Test Kit
  • Medomics New Novel Virus & Influenza a/B Rapid Test Kit
  • Medomics New Novel Virus & Influenza a/B Rapid Test Kit
  • Medomics New Novel Virus & Influenza a/B Rapid Test Kit
Find Similar Products

Basic Info.

Model NO.
Antigen Test
Certification
CE, ISO13485
Certificate
ISO, CE
Transport Package
Box+Carton
Trademark
OBM/OEM
Origin
China
HS Code
3002150090
Production Capacity
5, 000, 000 Pieces/Month

Product Description

Medomics New Novel Virus & Influenza a/B Rapid Test Kit
Medomics Flu & RSV Antigen Combo Rapid Test Kit (LFIA) : Respiratory tract infections are one of the most important causes of human illness and death. There are many pathogens that cause respiratory infections, including bacteria, viruses, and mycoplasma, with viruses in particular being the most common. Although the clinical signs and symptoms of respiratory tract infections are similar, the treatment of infections caused by different types of pathogens varies greatly, as do the efficacy and course of the disease; therefore, rapid and accurate detection and identification of pathogenic microrganisms can help in clinical diagnosis and treatment.
 
Intended use
Virus Flu & RSV Antigen Combo Rapid Test Kit (LFIA) is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of virus, Inflfluenza A , Inflfluenza B and RSV virus antigen in swab samples from individuals suspected of virus, Inflfluenza A , Inflfluenza B and RSV within the fifirst seven days of symptom onset. Virus & Inflfluenza A/B Antigen Combo Rapid Test Kit (LFIA) shall not be used as sole basis to diagnose or exclude virus, Inflfluenza A , Inflfluenza B and RSV infection.
Medomics New Novel Virus & Influenza a/B Rapid Test Kit
 
Medomics New Novel Virus & Influenza a/B Rapid Test Kit

*Test cassette: contains the virus & Flu & RSV Antigen test strip and a plastic cassette casing.Virus& Flu & RSV Antigen test strip contains anti-virus Nucleocapsid  Protein antibody labeled with colloidal gold, anti-Inflfluenza A Nucleocapsid Protein antibody labeled with colloidal gold, anti-Inflfluenza B Nucleocapsid Protein antibody labeled with colloidal gold anti-RSV antibody labeled with colloidal gold. Another anti-virus Nucleocapsid Protein antibody, anti-Inflfluenza A Nucleocapsid Protein antibody, anti-Inflfluenza B Nucleocapsid Protein antibody and anti-RSV antibody are fixed on the N line, A line , B line and R line respectively. The N line/A line/B line / R line and control line (C line) are in the detection window on the nitrocellulose membrane.
 
Storage Instructions:
The test kit should be stored away from direct sunlight at 2ºC to 30ºC with a shelf-life of  24 months. Do not freeze.

 
Sample Requirements
One test cassette can only be used to test one sample type. Sample types include  anterior nasal secretion, nasopharyngeal secretion and throat secretion.

Medomics New Novel Virus & Influenza a/B Rapid Test Kit
Sample should be treated with lysis buffer provided in this kit as soon as possible after collection. If the sample cannot be processed immediately, it should be stored immediately in a dry, sterilized and strictly sealed plastic tube. It can be stored at 2ºC-8ºC for 8 hours. Could be stored at -70ºC for long term storage.
Test Procedure:
Do not open pouch until ready to use. Prep necessary materials: Timer | Tube rack for sampling tubes and specimens | Any necessary personal protective equipment. 1 | Sampling: Vertically add 15 drops (approximately 350 μL) lysis buffer into the sampling tube from vial or open the seal of the sampling tube containing lysis buffer or twist and squeeze out all the lysis bffer into the sampling tube from capsule. Insert the swab (after collection) into the buffer. Rotate the swab against the inner tube wall 10 times and squeeze the swab from the outer tube wall 5 times to completely dissolve the sample in the buffer, then move the swab up until it is resting on the sample solution, squeeze the swab from the outer tube wall in order to leave the sample in the tube as much as possible.

Remove and discard the swab, cover the tube with the dropper. 2 | Test procedures: Open the aluminum foil pouch, take out the test cassette and lay it on a clean flflat surface, then mark the cassette with the patient ID or sample number and add 4 drops (approximately 100 μL) processed sample extract into the sample well. The result should be observed within 15-20 minutes. Results observed after 20 minutes are invalid.
Medomics New Novel Virus & Influenza a/B Rapid Test Kit
About Medomics


Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.  

Medomics owns two R&D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 10,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Until now, Medomics has more than 100 employees across the world and R&D personnel accounts for over 50%. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions.


Medomics New Novel Virus & Influenza a/B Rapid Test Kit
Contact Medomics
Medomics New Novel Virus & Influenza a/B Rapid Test Kit

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier